Chondroitinase treatment increases the effective length of acellular nerve grafts.
Acellular nerve allografts have been explored as an alternative to nerve autografting. It has long been recognized that there is a distinct limit to the effective length of conventional acellular nerve grafts, which must be overcome for many grafting applications. In rodent models nerve regeneration fails in acellular nerve grafts greater than 2 cm in length. In previous studies we found that nerve regeneration is markedly enhanced with acellular nerve grafts in which growth-inhibiting chondroitin sulfate proteoglycan was degraded by pretreatment with chondroitinase ABC (ChABC). Here, we tested if nerve regeneration can be achieved through 4-cm acellular nerve grafts pretreated with ChABC. Adult rats received bilateral sciatic nerve segmental resection and repair with a 4 cm, thermally acellularized, nerve graft treated with ChABC (ChABC graft) or vehicle-treated acellularized graft (Control graft). Nerve regeneration was examined 12 weeks after implantation. Our findings confirm that functional axonal regeneration fails in conventional long acellular grafts. In this condition we found very few axons in the distal host nerve, and there were marginal signs of sciatic nerve reinnervation in few (2/9) rats. This was accompanied by extensive structural disintegration of the distal graft and abundant retrograde axonal regeneration in the proximal nerve. In contrast, most (8/9) animals receiving nerve repair with ChABC grafts showed sciatic nerve reinnervation by direct nerve pinch testing. Histological examination revealed much better structural preservation and axonal growth throughout the ChABC grafts. Numerous axons were found in all but one (8/9) of the host distal nerves and many of these regenerated axons were myelinated. In addition, the amount of aberrant retrograde axonal growth (originating near the proximal suture line) was markedly reduced by repair with ChABC grafts. Based on these results we conclude that ChABC treatment substantially increases the effective length of acellular nerve grafts.
Neubauer
Debbie
D
Department of Pediatrics, Neurology Division and the McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL 32610-0296, USA.
Graham
James B
JB
Muir
David
D
D000818:Animals; D001369:Axons / Q000473:pathology / Q000648:ultrastructure; D002474:Cell-Free System / Q000187:drug effects* / Q000473:pathology / Q000637:transplantation*; D019765:Chondroitin ABC Lyase / Q000494:pharmacology*; D008297:Male; D009186:Myelin Sheath / Q000648:ultrastructure; D009416:Nerve Regeneration / Q000187:drug effects; D010812:Physical Stimulation; D051381:Rats; D011916:Rats, Inbred F344; D012584:Sciatic Nerve / Q000293:injuries* / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*
D019765:Chondroitin ABC Lyase